Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Scand J Immunol ; 99(3): e13357, 2024 Mar.
Article in English | MEDLINE | ID: mdl-39008023

ABSTRACT

Group 2 innate lymphoid cells (ILC2s) are a type of innate immune cells that produce a large amount of IL-5 and IL-13 and two cytokines that are crucial for various processes such as allergic airway inflammation, tissue repair and tissue homeostasis. It is known that damaged epithelial-derived alarmins, such as IL-33, IL-25 and thymic stromal lymphopoietin (TSLP), are the predominant ILC2 activators that mediate the production of type 2 cytokines. In recent years, abundant studies have found that many factors can regulate ILC2 development and function. Hormones synthesized by the body's endocrine glands or cells play an important role in immune response. Notably, ILC2s express hormone receptors and their proliferation and function can be modulated by multiple hormones during allergic airway inflammation. Here, we summarize the effects of multiple hormones on ILC2-driven allergic airway inflammation and discuss the underlying mechanisms and potential therapeutic significance.


Subject(s)
Cytokines , Immunity, Innate , Lymphocytes , Humans , Immunity, Innate/immunology , Animals , Lymphocytes/immunology , Lymphocytes/metabolism , Cytokines/metabolism , Cytokines/immunology , Hormones/metabolism , Hormones/immunology , Inflammation/immunology , Asthma/immunology
2.
Immunology ; 164(2): 223-230, 2021 10.
Article in English | MEDLINE | ID: mdl-33930194

ABSTRACT

Mycoplasmas are the smallest and simplest bacteria that lack a cell wall but have the capability of self-replication. Among them, Mycoplasma pneumoniae is one of the most common causes of community-acquired pneumonia. The hallmark of mycoplasma respiratory diseases is the persistence of lung inflammation that involves both innate and adaptive immune responses. In recent years, a growing body of evidence demonstrates that IL-17 plays an important role in respiratory mycoplasma infection, and associates with the pathologic outcomes of infection, such as pneumonitis and asthma. Numerous studies have shown that a variety of cells, in particular Th17 cells, in the lung can secrete IL-17 during respiratory mycoplasma infection. In this article, we review the biological functions of distinct IL-17-producing cells in mycoplasma respiratory infection with a focus on the effect of IL-17 on the outcomes of infection.


Subject(s)
Interleukin-17/immunology , Mycoplasma Infections/immunology , Mycoplasma pneumoniae/immunology , Respiratory Tract Infections/immunology , Animals , Asthma/immunology , Humans , Lung/immunology , Pneumonia/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...